Literature DB >> 19775606

Impact of molecular markers on treatment selection in advanced colorectal cancer.

Hans Prenen1, Sabine Tejpar, Eric Van Cutsem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19775606     DOI： 10.1016/S0959-8049(09)70018-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Heterogeneity in the colorectal primary tumor and the synchronous resected liver metastases prior to and after treatment with an anti-EGFR monoclonal antibody.

Authors:  Daniela Adua; Francesca Di Fabio; Giorgio Ercolani; Michelangelo Fiorentino; Elisa Gruppioni; Annalisa Altimari; Fabiola Lorena Rojas Limpe; Nicola Normanno; Antonio Daniele Pinna; Carmine Pinto
Journal:  Mol Clin Oncol       Date:  2017-05-23

2.  Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients.

Authors:  Zacharenia Saridaki; Maria Tzardi; Chara Papadaki; Maria Sfakianaki; Fraga Pega; Aristea Kalikaki; Eleftheria Tsakalaki; Maria Trypaki; Ippokratis Messaritakis; Efstathios Stathopoulos; Dimitris Mavroudis; Vassilis Georgoulias; John Souglakos
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

3.  The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.

Authors:  Nicky D'Haene; Caroline Koopmansch; Yves-Rémi Van Eycke; Françoise Hulet; Justine Allard; Sarah Bouri; Sandrine Rorive; Myriam Remmelink; Christine Decaestecker; Calliope Maris; Isabelle Salmon
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.